List your tool

Head to head · 2026

Enlitic vs SOPHiA GENETICS

Pricing, free plans, ratings, features, pros and cons, side by side. Where one comes out ahead, we mark it.

Enlitic

Deep-learning chest X-ray analysis (CXR-AI) sped radiologist interpretation over 20% in early trials - the first…

3.9Not listed

Visit Enlitic (opens Enlitic in a new tab)

SOPHiA GENETICS

AI genomic analytics at 98-99% accuracy, deployed across 1,000+ healthcare institutions in 75+ countries - 2.6…

3.9Not listed

Visit SOPHiA GENETICS (opens SOPHiA GENETICS in a new tab)

Who comes out ahead

Based only on the facts in our directory. The right pick still depends on the job you need done.

  • Lower starting price

    Not comparable

    Not comparable: Enlitic does not list a price

  • Free plan

    Tie

    Neither has one

  • Higher rating

    Tie

    3.9 against 3.9

  • Same job?

    Yes

    Both are Healthcare AI tools

Side by side

Compared onEnliticSOPHiA GENETICS
Our rating3.93.9
Starts atNot listedNot listed
Free planNoNo
CategoryHealthcare AIHealthcare AI
PlansSee pricingSee pricing
Key features
  • CXR-AI - deep-learning chest X-ray abnormality detection
  • ENDEX - AI-based medical image data standardization
  • Curie platform for real-world evidence data infrastructure
  • Regulatory approval to commercialize in Japan
  • Measured 20%+ faster radiologist interpretation in early trials
  • SOPHiA DDM - AI genomic and radiomic analysis platform
  • 98-99% accuracy across 2.6M+ analyzed genomic profiles
  • Oncology coverage - solid tumors, blood cancers, hereditary cancers, liquid biopsy
  • Rare and inherited disorder analysis
  • HIPAA/GDPR-compliant cloud infrastructure
Pros
  • Regulatory approval (Japan) is a concrete, third-party-verifiable claim
  • Measured clinical performance gains (speed, true/false positive rates), not just marketing claims
  • ENDEX addresses the unglamorous but real problem of inconsistent imaging-archive labeling
  • Accuracy claims are backed by scale (2.6M+ profiles), not a small validation sample
  • Deployed across a genuinely large, verifiable institutional network (1,000+ sites, 75+ countries)
  • Covers both oncology and rare/inherited disorder use cases
Cons
  • Enterprise healthcare infrastructure - not accessible to individual practitioners or consumers
  • No published pricing - a hospital/health-system sales process
  • Regulatory approval varies by country - Japan approval doesn't guarantee approval elsewhere
  • No published pricing - an institutional sales process
  • Built for healthcare institutions, not individual practitioners or patients directly
  • Requires integration into existing clinical genomics/pathology workflows
CompanyEnliticSOPHiA GENETICS

Prices come from each vendor's pricing page, last checked 20260824. Check the vendor before you buy.

FAQ

Questions people ask

Is Enlitic better than SOPHiA GENETICS?

In our reviews Enlitic scores 3.9 and SOPHiA GENETICS scores 3.9. The better pick depends on the job. Enlitic: Deep-learning chest X-ray analysis (CXR-AI) sped radiologist interpretation over 20% in early trials - the first U.S. imaging AI company approved to commercialize in Japan. SOPHiA GENETICS: AI genomic analytics at 98-99% accuracy, deployed across 1,000+ healthcare institutions in 75+ countries - 2.6 million-plus genomic profiles analyzed to date.

Which is cheaper, Enlitic or SOPHiA GENETICS?

Enlitic: see pricing. SOPHiA GENETICS: see pricing.

Do Enlitic and SOPHiA GENETICS have free plans?

Neither lists a free plan.

More comparisons